Abstract:Vanishing bile duct syndrome (VBDS) is a rare and potentially life-threatening disorder in which progressive destruction and disappearance of small intrahepatic bile ducts occur, with resultant cholestasis. The mechanism by which biliary epithelial cells are damaged and intrahepatic bile ducts are lost has not been fully elucidated. However, many etiologies have been reported,and several drugs have been implicated. Meropenem is a widely used, well tolerated broad-spectrum carbapenem antibiotic indicated for the treatment of intraabdominal infections, complicated skin and skin structure infections, and pediatric bacterial meningitis. We describe what we believe is the first reported case of meropenem-induced VBDS. A 60-year-old woman was diagnosed with VBDS after being treated with meropenem for a left temporal lobe brain abscess. Three weeks after starting the drug, the patient developed mixed hepatocellular and cholestatic liver injury with jaundice and pruritus.Meropenem-induced liver injury was suspected, and the drug was discontinued. Diagnostic tests ruled out other causes of cholestasis, including infectious and immunologic conditions. A liver biopsy, performed due to persistent liver injury, demonstrated an absence of bile ducts, which, in conjunction with the patient's clinical course, was consistent with the diagnosis of VBDS. Several months after the cessation of meropenem, the patient's liver function test results improved. Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 6)between the patient's development of VBDS and meropenem therapy. A high index of suspicion is necessary to diagnose VBDS and other types of drug induced liver injury. Clinicians should consider VBDS as a potential diagnosis in patients receiving meropenem who have prolonged cholestasis, especially after other more probable causes have been excluded.

S4299 A Clinical Puzzle: A Case of Vanishing Bile Duct Syndrome

S4576 Unique Case of Vanishing Bile Duct Syndrome Exacerbated by Noncompliance

Vanishing Bile Duct Syndrome: A Differential Diagnosis for Painless Jaundice

S2484 Vanishing Bile Duct Syndrome Resulting From HIV Viremia: A Case Report

Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission

Drug Associated Vanishing Bile Duct Syndrome Combined with Hemophagocytic Lymphohistiocytosis

Acute Vanishing Bile Duct Syndrome after Therapy with Cephalosporin, Metronidazole, and Clotrimazole A Case Report

Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome

Research Advances in Drug-Induced Vanishing Bile Duct Syndrome

Duplication of the extrahepatic bile duct: A case report and review of the literatures.

S4304 Cholangitis Lenta and Giant Cell Hepatitis: A Unique Coexistence

S2475 A Radiological and Clinical Challenge: Congenital Intrahepatic Gallbladders

S4473 Bile Duct Ballet: Dancing With Von Meyenburg Complexes and Liver Enzyme Riddles - Diagnostic Dilemma

S2381 Exploring the Anomalies: A Case of Type Va Duplication of Extrahepatic Biliary Ducts Identified on MRCP

S2723 Image Negative Ascending Cholangitis in the Setting of Von Meyenburg Complex

S4329 Obliterative Portal Venopathy: A Case of Non-Cirrhotic Variceal Bleed

S4544 A Case of Caroli's Disease in the Setting of Poor Access to Liver Transplant Services

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

Meropenem-induced vanishing bile duct syndrome

S4271 Autoimmune Cholangitis: A Rare Case of Silent Liver Cirrhosis

Synchronous Liver Abscess With Cholecystitis: A Rare Case of Initial Presentation of Gallbladder Cancer Posing a Diagnosis Challenge